Artem Andrianov, PhD

Articles

Risk Based Budgeting

April 24, 2018

Adoption of the concept of Risk-Based Budgeting could help maintain the trial budget or even save the whole clinical trial.

BlockChain in Clinical Trials—the Ultimate Data Notary

March 13, 2018

The clinical trials industry craves blockchain technology to provide data safety and authenticity.

Data from Global RACT Analysis Reveals Subjectivity

May 11, 2016

The biopharmaceutical industry is starting to adopt TransCelerate’s Risk Assessment Categorization Tool (RACT) in order to identify risks and plan a comprehensive clinical trial risk mitigation strategy. We recently wrote about the RACT moving to the cloud, and the advantages of using such systems. Some of these advantages include the ability for study teams to evaluate R&D portfolio risks by collecting and analyzing RACT data in aggregate.

ICH GCP Goes Risk Based

October 20, 2015

In this article, you will find a structured summary and critical review of the new addendum, and as well as ideas on how to prepare for these regulatory changes.